Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Kennis over RSV in West-Europa is laag, bereidheid vaccinatie is hoog
dec 2024 | Vaccinatie, Virale infecties